vs
Side-by-side financial comparison of Black Stone Minerals, L.P. (BSM) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $95.2M, roughly 1.7× Black Stone Minerals, L.P.). Black Stone Minerals, L.P. runs the higher net margin — 75.9% vs -82.0%, a 157.8% gap on every dollar of revenue. On growth, Black Stone Minerals, L.P. posted the faster year-over-year revenue change (-8.7% vs -22.7%). Over the past eight quarters, Black Stone Minerals, L.P.'s revenue compounded faster (-9.7% CAGR vs -11.5%).
Black Stone Minerals, L.P., or Black Stone Minerals, is a Houston, Texas-based oil and natural gas corporation.
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
BSM vs PTCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $95.2M | $164.7M |
| Net Profit | $72.2M | $-135.0M |
| Gross Margin | — | — |
| Operating Margin | 78.6% | -43.3% |
| Net Margin | 75.9% | -82.0% |
| Revenue YoY | -8.7% | -22.7% |
| Net Profit YoY | 55.8% | -104.8% |
| EPS (diluted) | — | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $95.2M | $164.7M | ||
| Q3 25 | $105.2M | $211.0M | ||
| Q2 25 | $106.7M | $178.9M | ||
| Q1 25 | $115.3M | $1.2B | ||
| Q4 24 | $104.3M | $213.2M | ||
| Q3 24 | $103.2M | $196.8M | ||
| Q2 24 | $115.2M | $186.7M | ||
| Q1 24 | $116.8M | $210.1M |
| Q4 25 | $72.2M | $-135.0M | ||
| Q3 25 | $91.7M | $15.9M | ||
| Q2 25 | $120.0M | $-64.8M | ||
| Q1 25 | $15.9M | $866.6M | ||
| Q4 24 | $46.3M | $-65.9M | ||
| Q3 24 | $92.7M | $-106.7M | ||
| Q2 24 | $68.3M | $-99.2M | ||
| Q1 24 | $63.9M | $-91.6M |
| Q4 25 | 78.6% | -43.3% | ||
| Q3 25 | 89.5% | 1.4% | ||
| Q2 25 | — | -19.5% | ||
| Q1 25 | 14.9% | 82.5% | ||
| Q4 24 | 45.6% | -76.2% | ||
| Q3 24 | 90.2% | -27.7% | ||
| Q2 24 | 59.5% | -21.5% | ||
| Q1 24 | 54.8% | -21.6% |
| Q4 25 | 75.9% | -82.0% | ||
| Q3 25 | 87.2% | 7.5% | ||
| Q2 25 | 112.5% | -36.3% | ||
| Q1 25 | 13.8% | 73.7% | ||
| Q4 24 | 44.4% | -30.9% | ||
| Q3 24 | 89.9% | -54.2% | ||
| Q2 24 | 59.3% | -53.1% | ||
| Q1 24 | 54.7% | -43.6% |
| Q4 25 | — | $-1.63 | ||
| Q3 25 | — | $0.20 | ||
| Q2 25 | — | $-0.83 | ||
| Q1 25 | — | $10.04 | ||
| Q4 24 | — | $-0.85 | ||
| Q3 24 | — | $-1.39 | ||
| Q2 24 | — | $-1.29 | ||
| Q1 24 | — | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.5M | $1.9B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $-205.3M |
| Total Assets | $1.3B | $2.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.5M | $1.9B | ||
| Q3 25 | $2.9M | $1.7B | ||
| Q2 25 | $2.5M | $2.0B | ||
| Q1 25 | $2.4M | $2.0B | ||
| Q4 24 | $2.5M | $1.1B | ||
| Q3 24 | $21.0M | $1.0B | ||
| Q2 24 | $26.7M | $1.1B | ||
| Q1 24 | $40.5M | $884.8M |
| Q4 25 | — | $-205.3M | ||
| Q3 25 | — | $-155.8M | ||
| Q2 25 | — | $-206.5M | ||
| Q1 25 | — | $-185.8M | ||
| Q4 24 | — | $-1.1B | ||
| Q3 24 | — | $-1.1B | ||
| Q2 24 | — | $-980.2M | ||
| Q1 24 | — | $-893.9M |
| Q4 25 | $1.3B | $2.9B | ||
| Q3 25 | $1.3B | $2.6B | ||
| Q2 25 | $1.3B | $2.6B | ||
| Q1 25 | $1.2B | $2.7B | ||
| Q4 24 | $1.2B | $1.7B | ||
| Q3 24 | $1.2B | $1.8B | ||
| Q2 24 | $1.2B | $1.9B | ||
| Q1 24 | $1.2B | $1.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $65.1M | $-34.3M |
| Free Cash FlowOCF − Capex | — | $-36.6M |
| FCF MarginFCF / Revenue | — | -22.3% |
| Capex IntensityCapex / Revenue | — | 1.4% |
| Cash ConversionOCF / Net Profit | 0.90× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $65.1M | $-34.3M | ||
| Q3 25 | $99.8M | $-66.3M | ||
| Q2 25 | $80.5M | $-58.3M | ||
| Q1 25 | $64.8M | $870.1M | ||
| Q4 24 | $91.0M | $-30.0M | ||
| Q3 24 | $93.2M | $-77.0M | ||
| Q2 24 | $100.4M | $-71.5M | ||
| Q1 24 | $104.5M | $70.8M |
| Q4 25 | — | $-36.6M | ||
| Q3 25 | — | $-69.7M | ||
| Q2 25 | — | $-59.6M | ||
| Q1 25 | — | $868.4M | ||
| Q4 24 | — | $-33.8M | ||
| Q3 24 | — | $-77.5M | ||
| Q2 24 | — | $-78.8M | ||
| Q1 24 | — | $61.2M |
| Q4 25 | — | -22.3% | ||
| Q3 25 | — | -33.1% | ||
| Q2 25 | — | -33.3% | ||
| Q1 25 | — | 73.8% | ||
| Q4 24 | — | -15.8% | ||
| Q3 24 | — | -39.4% | ||
| Q2 24 | — | -42.2% | ||
| Q1 24 | — | 29.1% |
| Q4 25 | — | 1.4% | ||
| Q3 25 | — | 1.6% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 1.8% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 4.0% | ||
| Q1 24 | — | 4.6% |
| Q4 25 | 0.90× | — | ||
| Q3 25 | 1.09× | -4.17× | ||
| Q2 25 | 0.67× | — | ||
| Q1 25 | 4.07× | 1.00× | ||
| Q4 24 | 1.96× | — | ||
| Q3 24 | 1.01× | — | ||
| Q2 24 | 1.47× | — | ||
| Q1 24 | 1.63× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BSM
| Oil Reserves | $46.4M | 49% |
| Natural Gas Reserves | $44.1M | 46% |
| Real Estate | $4.7M | 5% |
PTCT
Segment breakdown not available.
